AAP Pediatric COVID-19 Vaccine Dosing Quick Reference Guide.
A 2-dose primary series using any combination of doses from either of the Moderna COVID-19 Vaccine products authorized for children ages 6 – 11 years or persons ages 12 – 17 years.A 2-dose primary series using the Moderna COVID-19 Vaccine product authorized for 12 – 17 years.A 2-dose primary series using any combination of doses from either of the Moderna COVID-19 Vaccine products authorized for children 6 months – 5 years or children ages 6 – 11 years.Ĭhildren who will turn from age 11 to 12 years: The FDA authorization of these vaccine products allow children who will turn from age 11 years to 12 years between any doses in the primary series to receive:.A 2-dose primary series using the Moderna COVID-19 Vaccine product authorized for children ages 6 – 11 years.